PUBLISHER: Allied Market Research | PRODUCT CODE: 1225065
PUBLISHER: Allied Market Research | PRODUCT CODE: 1225065
The medical device analytical testing outsourcing market valued for $4,744.84 million in 2021 and is estimated to reach $7,956.99 million by 2031, exhibiting a CAGR of 5.3% from 2022 to 2031.
Medical device analytical testing outsourcing refers to a specific type of contract between the manufacturer and the third-party companies for manufacturing, validation, packing, prototyping, designing, and verifying the medical devices in a sterile and controlled environment for supply chain management. In order to reduce business risks, accelerate product business expansion, and reduce costs, many medical device manufacturers companies go under outsource analytical testing activities. Electronics, finished products, and raw materials are the three main product categories in medical device outsourcing. The major factors driving the growth of global medical device analytical testing outsourcing market are rise in number of key players manufacturing medical devices and high adoption of analytical testing services for medical devices. In addition, rise in prevalence of chronic diseases has led to surge in the demand for new quality medical products, which also increases the adoption of outsourcing testing services. Conversely, the delay in medical devices approval due to lengthy procedure and time restrains the market growth. However, high growth potential in developing economies provide the lucrative opportunity to market growth.
The medical device analytical testing outsourcing market is segmented into service, end user, and region. By service, the market is categorized into physical testing, bioburden testing, sterility testing, and others. On the basis of end user, the market is segregated into medical device manufacturer and pharmaceutical companies. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global medical device analytical testing outsourcing market are Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific, Intetek Group plc, Pace Analytical, Medistri SA, North American Science Associates, LLC, SGS SA, The Smithers Group Inc., and WuXi AppTec.
Key Benefits For Stakeholders
By Service
By End User
By Region